Price
Target price
€3.65
€3.65
-0.220%
-0.008
-0.220%
€13.55
17.06.25 / Stuttgart Stock Exchange
WKN: A3DWPS / Symbol: KALA / Name: Kala Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Kala Pharmaceuticals Inc. Stock
The price for the Kala Pharmaceuticals Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.008 (-0.220%).
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Kala Pharmaceuticals Inc..
Based on the current price of 3.65 € the target price of 13 € shows a potential of 255.97% for Kala Pharmaceuticals Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Kala Pharmaceuticals Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Kala Pharmaceuticals Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Kala Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kala Pharmaceuticals Inc. | -0.220% | 0.882% | 31.655% | -32.535% | -43.168% | -80.157% | -99.363% |
| Krystal Biotech | 0.840% | -6.441% | -3.286% | -31.623% | -25.558% | 113.774% | - |
| Ardelyx Inc. | -1.800% | -5.292% | -10.932% | -47.221% | -37.644% | 490.614% | -47.077% |
| Evolus Inc | -2.370% | -0.588% | -1.744% | -17.157% | -19.524% | -22.477% | 87.778% |
Comments
KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $15.00 to $12.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO, Inc. (NASDAQ: KALA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Show more
Ratings data for KALA provided by MarketBeat